ArticleIn reply: The PARADIGM-HF trialAuthor:Miriam S. Jacob, MD Publish date: March 1, 2016The findings of PARADIGM-HF have sparked much conversation and implementation of practice change in the treatment of heart failure. Read More
ArticleA new class of drugs for systolic heart failure: The PARADIGM-HF studyAuthor:Miriam S. Jacob, MD Publish date: October 1, 2015Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure. Read More
